Experience

ASC Therapeutics

• United States
• Biotechnology
• 1 - 100 Employee

• Senior Director, CMC Head, Cell and Gene Therapy

  • Aug 2021 - Present

• Director, CMC Head, Cell and Gene Therapy

  • Apr 2020 - Jul 2021

  San Francisco Bay Area AAV Viral Vector, Process development, CMC, Cell and Gene Therapy, Manufacturing

• Associate Director, CMC

  • Jul 2019 - Mar 2020

  Bay Area

• Senior Manager, CMC

  • Mar 2019 - Jun 2019

  San Francisco Bay Area Process development, Cell and Gene Therapy, Manufacturing and Testing



Orchard Therapeutics

• United Kingdom
• Biotechnology
• 100 - 200 Employee

• Manager, Vector Operations

  • Jan 2018 - Feb 2019

  California



Adicet Bio, Inc

• United States
• Biotechnology Research
• 1 - 100 Employee

• Senior Manager, Viral Vector and Allogeneic CarT Engineering

  • Apr 2017 - Jan 2018

  Bay Area, California Allogeneic CarT engineering; Viral vector research development and process development. Genetic Modification of Allogeneic CarT cells using viral vector



Epeius Biotechnologies Corp

• United States
• Biotechnology Research
• 1 - 100 Employee

• Translational Scientist

  • Sep 2014 - Apr 2017

  Greater Los Angeles Area Translational Scientist/ Viral vector process development and production Cancer therapy clinical trial; Technology transfer; Upstream and down stream process. Large scale cell manipulation. Manufacturing (cGMP); Assay development; GLP.



City of Hope

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Staff Scientist

  • Apr 2005 - Sep 2014

  Duarte, CA o Set up gene therapy/cell therapy platform and conducted clinical trial; Stem Cell Therapy/Tcell therapy using lentiviral vector. o cGMP large scale stem cell process and T cell expansion process; manufacturing of stem cell and T cell therapeutic for clinical trial; o Genetic modification of T cells and stem cell using lentiviral vectors, adenoviral vector, AAV vector, electroporation; development of characterization assays and QC assays for cellular therapeutic products; actively… Show more o Set up gene therapy/cell therapy platform and conducted clinical trial; Stem Cell Therapy/Tcell therapy using lentiviral vector. o cGMP large scale stem cell process and T cell expansion process; manufacturing of stem cell and T cell therapeutic for clinical trial; o Genetic modification of T cells and stem cell using lentiviral vectors, adenoviral vector, AAV vector, electroporation; development of characterization assays and QC assays for cellular therapeutic products; actively involved in IND application o Led the team conducted pre-clinical studies and process development on genetic modification of Hematopoietic Stem/Progenitor Cells using Zinc Finger Nuclease (ZFN), applied viral vectors or non-viral vector gene delivery technologies; o SOPs and batch record for cell process, manufacturing process, quality control, product release, instrument operation and maintenance; o Coordinated activities among multiple cross function teams; designed and conducting experiments, analyzed/summarized data; wrote and edit manuscripts, reports, and documents for IND; presented results in national and international conferences; Show less